Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

CT and MR imaging of neuroaxonal leukodystrophy presenting as early-onset frontal dementia.

Mascalchi M, Gavazzi C, Morbin M, Giaccone G, Arnetoli G, Zappoli R, Bugiani O.

AJNR Am J Neuroradiol. 2006 May;27(5):1037-9.

3.

Frontal and parieto-temporal cortical ablations and diaschisis-like effects on auditory neurocognitive potentials evocable from apparently intact ipsilateral association areas in humans: five case reports.

Zappoli R, Zappoli F, Picchiecchio A, Chiaramonti R, Grazia Arneodo M, Zappoli Thyrion GD, Zerauschek V.

Int J Psychophysiol. 2002 May;44(2):117-42.

PMID:
11909646
4.

The effects on auditory neurocognitive evoked responses and contingent negative variation activity of frontal cortex lesions or ablations in man: three new case studies.

Zappoli R, Versari A, Zappoli F, Chiaramonti R, Zappoli Thyrion GD, Grazia Arneodo M, Zerauschek V.

Int J Psychophysiol. 2000 Nov;38(2):109-44.

PMID:
11024574
5.

Presenile primary cognitive decline or Alzheimer's dementia: 7-year clinical and neuropsychological follow-up.

Zappoli R, Paganini M, Arnetoli G, Bracco L, Battaglia A, Chiaramonti R, Arneodo MG.

Ital J Neurol Sci. 1999 Apr;20(2):109-17.

PMID:
10933431
6.

Cognitive potentials and corticocortical connections in humans.

Zappoli R, Zappoli Thyrion GD.

Electroencephalogr Clin Neurophysiol Suppl. 1999;50:74-84. Review. No abstract available.

PMID:
10689448
7.

The so-called 'mind/brain dualism', the 'bicameral mind' and 'the double brain'.

Zappoli R.

Int J Psychophysiol. 1999 Aug;33(2):182-3. No abstract available.

PMID:
10489083
8.

Decreased EEG microstate duration and anteriorisation of the brain electrical fields in mild and moderate dementia of the Alzheimer type.

Strik WK, Chiaramonti R, Muscas GC, Paganini M, Mueller TJ, Fallgatter AJ, Versari A, Zappoli R.

Psychiatry Res. 1997 Oct 31;75(3):183-91.

PMID:
9437775
9.

Brain electrical activity (quantitative EEG and bit-mapping neurocognitive CNV components), psychometrics and clinical findings in presenile subjects with initial mild cognitive decline or probable Alzheimer-type dementia.

Zappoli R, Versari A, Paganini M, Arnetoli G, Muscas GC, Gangemi PF, Arneodo MG, Poggiolini D, Zappoli F, Battaglia A.

Ital J Neurol Sci. 1995 Sep;16(6):341-76. Review.

PMID:
8626214
10.

Cognitive potentials: ipsilateral corticocortical interconnections in prefrontal human cortex ablations.

Zappoli R, Zappoli F, Versari A, Arnetoli G, Paganini M, Arneodo MG, Poggiolini D, Thyrion EZ.

Neurosci Lett. 1995 Jun 30;193(2):140-4.

PMID:
7478161
11.
12.

Changes in bit-mapped contingent negative variation (CNV) activity due to initial normal involutional processes of the human brain.

Zappoli R, Versari A, Paganini M, Arnetoli G, Gangemi PF, Muscas GC, Arneodo MG, Battaglia A.

Int J Psychophysiol. 1992 Mar;12(2):101-21.

PMID:
1592664
13.

Topographic CNV activity mapping, presenile mild primary cognitive decline and Alzheimer-type dementia.

Zappoli R, Versari A, Arnetoli G, Paganini M, Muscas GC, Arneodo MG, Gangemi PF, Bartelli M.

Neurophysiol Clin. 1991 Dec;21(5-6):473-83.

PMID:
1808505
14.

Effect of physiological and pathological aging processes on topographic bit-mapped cognitive evoked potentials in presenile subjects.

Zappoli R, Versari A, Arnetoli G, Paganini M, Muscas GC, Arneodo MG, Gangemi PF, Bartelli M.

Acta Neurol (Napoli). 1991 Dec;13(6):569-73.

PMID:
1805555
16.

Cognitive event-related potentials and reaction time in presenile subjects with initial mild cognitive decline or probable Alzheimer-type dementia.

Zappoli R, Versari A, Arnetoli G, Paganini M, Nencioni C, Roma V, Battaglia A, Maniero A, Ardia A.

Ital J Neurol Sci. 1990 Apr;11(2):113-30.

PMID:
2361850
17.

Diagnosis and follow-up of mitochondrial encephalomyopathy: CT and MR studies.

Taverni N, Dal Pozzo G, Arnetoli G, Zappoli R.

J Comput Assist Tomogr. 1988 Jul-Aug;12(4):696-7.

PMID:
3392284
18.

Age differences in contingent negative variation activity of healthy young adults and presenile subjects.

Zappoli R, Versari A, Paganini M, Arnetoli G, Roma V, Battaglia A, Porc├╣ S.

Ital J Neurol Sci. 1988 Jun;9(3):219-30.

PMID:
3403214
19.

Surface electric fields during CNV activity.

Denoth F, Navona C, Zappoli R.

Electroencephalogr Clin Neurophysiol Suppl. 1987;40:24-30. No abstract available.

PMID:
3480128
20.
21.

Lack of relationship between sodium valproate-induced adverse effects and the plasma concentration of its metabolite 2-propylpenten-4-oic acid.

Paganini M, Zaccara G, Moroni F, Campostrini R, Bendoni L, Arnetoli G, Zappoli R.

Eur J Clin Pharmacol. 1987;32(2):219-22.

PMID:
3108013
22.

Long-term treatment with sodium valproate: monitoring of venous ammonia concentrations and adverse effects.

Zaccara G, Campostrini R, Paganini M, Messori A, Valenza T, Arnetoli G, Zappoli R.

Ther Drug Monit. 1987;9(1):34-40.

PMID:
3107169
23.

Status epilepticus due to abrupt diazepam withdrawal: a case report.

Zaccara G, Innocenti P, Bartelli M, Casini R, Tozzi F, Rossi L, Zappoli R.

J Neurol Neurosurg Psychiatry. 1986 Aug;49(8):959-60. No abstract available.

24.

Current methodological issues in ERP research: some remarks and proposals. A review.

Denoth F, Zappoli R, Wenegrat B.

Electroencephalogr Clin Neurophysiol Suppl. 1986;38:3-17. Review. No abstract available.

PMID:
3539577
25.

Auditory and somatosensory evoked potentials (AEPs and SEPs) and ballistic movements in Parkinson disease.

Rossi L, Benvenuti F, Pantaleo T, Bindi A, Costantini S, De Scisciolo G, Zappoli R.

Ital J Neurol Sci. 1985 Sep;6(3):329-37.

PMID:
4066268
26.

Valproate-induced hyperammonaemia in two epileptic identical twins.

Campostrini R, Zaccara G, Rossi L, Paganini M, Dorigotti A, Zappoli R.

J Neurol. 1985;232(3):167-8.

PMID:
3928828
27.

Effect of associated antiepileptic treatment on valproate-induced hyperammonemia.

Zaccara G, Paganini M, Campostrini R, Moroni F, Valenza T, Messori A, Bartelli M, Arnetoli G, Zappoli R.

Ther Drug Monit. 1985;7(2):185-90.

PMID:
3927530
28.

Status epilepticus.

Michelucci R, Tassinari CA, Zappoli R.

Electroencephalogr Clin Neurophysiol Suppl. 1985;37:241-65.

PMID:
3924562
29.

Pseudoperiodic paroxysmal discharge in a case of hemorrhagic shock.

Bindi A, Rossi L, de Scisciolo G, Zappoli F, Ammannati F, Zappoli R.

Ital J Neurol Sci. 1984 Dec;5(4):447-50.

PMID:
6442286
30.

Venous blood ammonia concentrations in adult epileptic patients are increased by treatment with valproic acid.

Paganini M, Zaccara G, Campostrini R, Valenza T, Angelastro R, Bartelli M, Arnetoli G, Zappoli R.

Acta Neurol (Napoli). 1984 Dec;6(6):442-6. No abstract available.

PMID:
6441459
31.

Acute changes of blood ammonia may predict short-term adverse effects of valproic acid.

Zaccara G, Campostrini R, Paganini M, Moroni F, Valenza T, Targioni G, Arnetoli G, Zappoli R, Baruzzi A.

Neurology. 1984 Nov;34(11):1519-21.

PMID:
6436733
32.

[Electrophysiologic studies (auditory and somatosensory evoked potentials) in Friedreich's ataxia].

Rossi L, Bindi A, De Scisciolo G, Russo G, Marini P, Zappoli R.

Riv Patol Nerv Ment. 1984 Jul-Aug;105(4):173-85. Italian.

PMID:
6571600
33.

Auditory evoked potentials (early, middle, late components) and audiological tests in Friedreich's ataxia.

Amantini A, Rossi L, De Scisciolo G, Bindi A, Pagnini P, Zappoli R.

Electroencephalogr Clin Neurophysiol. 1984 Jul;58(1):37-47.

PMID:
6203701
34.

Clinical application of the Mullen and Foster method for individualizing phenytoin dosage.

Valenza T, Messori A, Zaccara G, Arnetoli G, Bartoli C, Donati-Cori G, Muscas GC, Silvano R, Tendi E, Zappoli R.

Ital J Neurol Sci. 1984 Jun;5(2):195-200.

PMID:
6469541
35.

[Neuroradiologic and neurophysiologic studies in patients with olivo-ponto-cerebellar atrophy].

Rossi L, Zappoli F, De Scisciolo G, Bindi A, Costantini S, Amantini A, Ronchi O, Pagnini P, Marini P, Zappoli R.

Riv Neurobiol. 1984 Apr-Sep;30(2-3):575-89. Italian. No abstract available.

PMID:
6544507
36.

Posterior alpha activity during vertex-CNV formation under different stimulating conditions. A new approach.

Denoth F, Zappoli R, Navona C, Ragazzoni A.

Ann N Y Acad Sci. 1984;425:177-87. No abstract available.

PMID:
6588827
37.

Hyperammonemia and valproate-induced alterations of the state of consciousness. A report of 8 cases.

Zaccara G, Paganini M, Campostrini R, Arnetoli G, Zappoli R, Moroni F.

Eur Neurol. 1984;23(2):104-12.

PMID:
6426961
38.

A new programmable calculator procedure for individualizing phenytoin dosage.

Messori A, Valenza T, Zaccara G, Arnetoli G, Bartoli C, Donati-Cori G, Tendi E, Zappoli R.

Drug Intell Clin Pharm. 1983 Dec;17(12):890-3.

PMID:
6653404
39.

Treatment of epileptic patients with valproic acid does not modify plasma and urine short-chain-fatty acids.

Zaccara G, Boncinelli L, Paganini M, Campostrini R, Arnetoli G, Zappoli R.

Acta Neurol Scand. 1983 Oct;68(4):241-7.

PMID:
6419536
40.

Somatic brain-stem reflexes in vertebral-basilar insufficiency: an electrophysiological study.

Ronchi O, Arnetoli G, Campostrini R, Nencioni L, Zappoli R.

Electromyogr Clin Neurophysiol. 1983 Sep-Oct;23(6):577-85. No abstract available.

PMID:
6641611
41.

Comparison of two pharmacokinetic methods for individualizing phenytoin dosage.

Zaccara G, Messori A, Valenza T, Arnetoli G, Bartoli C, Donati-Cori G, Muscas GC, Tendi E, Zappoli R.

Boll Chim Farm. 1983 Mar;122(3):1S-6S. No abstract available.

PMID:
6680319
42.
43.

Electrophysiological investigations of the brainstem in the vertebrobasilar reversible attacks.

Rossi L, Amantini A, Bindi A, Pagnini P, Arnetoli G, Zappoli R.

Eur Neurol. 1983;22(5):371-9.

PMID:
6628464
44.

[Alterations of the state of consciousness induced by valproic acid: 6 case reports].

Campostrini R, Paganini M, Boncinelli L, Zaccara G, Arnetoli G, Zappoli R.

Riv Patol Nerv Ment. 1983 Jan-Feb;104(1):23-34. Italian.

PMID:
6431599
45.

BAEP and autopsy findings in Wallenberg syndrome.

Amantini A, Arnetoli G, Rossi L, Fenzi, Salviati A, Rizzuto N, Zappoli R.

Ital J Neurol Sci. 1982 Oct;3(3):237-40.

PMID:
7161039
46.

Brainstem auditory evoked potentials and vertebral-basilar reversible ischemic attacks.

Ragazzoni A, Amantini A, Rossi L, Pagnini P, Arnetoli G, Marini P, Nencioni C, Versari A, Zappoli R.

Adv Neurol. 1982;32:187-94. No abstract available.

PMID:
7054939
47.

Changes of vertex-CNV and parieto-occipital alpha activity under closed- and open-eye conditions.

Zappoli R, Denoth F, Navona C.

Prog Brain Res. 1980;54:62-5. No abstract available.

PMID:
7220976
48.

Neurophysiological mechanisms in psychotic children (EEG and ERSP) studies).

Papini M, Zappoli R, Pasquinelli A.

Act Nerv Super (Praha). 1977 Jul;19 Suppl 2:365-7. No abstract available.

PMID:
551661
49.

[CNV and SEP in shoe-industry workers affected by neuropathy due to toxic effects of adhesive solvents (author's transl)].

Zappoli R, Giuliano G, Rossi L, Papini M, Ronchi O, Ragazzoni A, Amantini A.

Riv Patol Nerv Ment. 1979 Jul-Aug;100(4):189-200. Italian.

PMID:
233478
50.

[Confusional states of epileptic nature with onset at menopause. Clinical studies of a case].

Zaccara G, Amantini A, Ciardella F, Franchi F, Rossi L, Zappoli Thyrion E, Zappoli R.

Riv Neurobiol. 1978 Oct-Dec;24(4):324-42. Italian. No abstract available.

PMID:
756611

Supplemental Content

Loading ...
Support Center